BRPI1014081A2 - uso de uma bactéria da espécie bifidobacterium animalis subsp lactis cepa 420 (b420) ou uma mistura da mesma - Google Patents

uso de uma bactéria da espécie bifidobacterium animalis subsp lactis cepa 420 (b420) ou uma mistura da mesma

Info

Publication number
BRPI1014081A2
BRPI1014081A2 BRPI1014081A BRPI1014081A BRPI1014081A2 BR PI1014081 A2 BRPI1014081 A2 BR PI1014081A2 BR PI1014081 A BRPI1014081 A BR PI1014081A BR PI1014081 A BRPI1014081 A BR PI1014081A BR PI1014081 A2 BRPI1014081 A2 BR PI1014081A2
Authority
BR
Brazil
Prior art keywords
bacterium
mixture
bifidobacterium animalis
lactis strain
animalis subsp
Prior art date
Application number
BRPI1014081A
Other languages
English (en)
Inventor
Didier Carcano
Remy Burcelin
Sampo Lahtinen
Original Assignee
Danisco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danisco filed Critical Danisco
Publication of BRPI1014081A2 publication Critical patent/BRPI1014081A2/pt
Publication of BRPI1014081B1 publication Critical patent/BRPI1014081B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/51Bifidobacterium
    • A23V2400/515Animalis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • A61K2035/115Probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI1014081-6A 2009-06-19 2010-06-18 Uso de uma bactéria bifidobacterium animalis subsp. lactis cepa 420 para tratar doenças em um mamífero BRPI1014081B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21856309P 2009-06-19 2009-06-19
US61/218,563 2009-06-19
PCT/IB2010/052757 WO2010146568A2 (en) 2009-06-19 2010-06-18 Bifidobacteria for treating diabetes and related conditions

Publications (2)

Publication Number Publication Date
BRPI1014081A2 true BRPI1014081A2 (pt) 2016-04-19
BRPI1014081B1 BRPI1014081B1 (pt) 2025-05-27

Family

ID=

Also Published As

Publication number Publication date
US20140348796A1 (en) 2014-11-27
WO2010146568A2 (en) 2010-12-23
WO2010146568A3 (en) 2011-05-05
ES2763137T3 (es) 2020-05-27
PL2808024T3 (pl) 2019-09-30
US20200316144A1 (en) 2020-10-08
US20230248786A1 (en) 2023-08-10
EP2442814B1 (en) 2018-09-26
EP2808024B1 (en) 2019-04-24
ES2729765T3 (es) 2019-11-06
US12594309B2 (en) 2026-04-07
CN104784694A (zh) 2015-07-22
CN104784220A (zh) 2015-07-22
PL2442814T3 (pl) 2019-04-30
US20210322491A1 (en) 2021-10-21
EP2442814A2 (en) 2012-04-25
CN102458415A (zh) 2012-05-16
DK3181134T3 (da) 2020-01-20
EP2808024A1 (en) 2014-12-03
US20190307815A1 (en) 2019-10-10
CN102458415B (zh) 2015-05-20
EP3181134A1 (en) 2017-06-21
EP3181134B1 (en) 2019-10-30
DK2442814T3 (en) 2019-01-14
CN104770739A (zh) 2015-07-15
US20250041358A1 (en) 2025-02-06
US20180021391A1 (en) 2018-01-25
DK2808024T3 (da) 2019-06-11
US20120107291A1 (en) 2012-05-03
PL3181134T3 (pl) 2020-04-30
CN104784219A (zh) 2015-07-22
ES2702977T3 (es) 2019-03-06

Similar Documents

Publication Publication Date Title
DK2318513T3 (da) Ny probiotisk bifidobacterium longum
LT3048165T (lt) Naujasis bifidobacterium animalis subsp. lactis cect 8145 štamas ir jo panaudojimas viršsvorio ir nutukimo ir susijusių ligų gydymui ir (arba) prevencijai
IL213039A (en) Human anti-angiopoietin-2 antibodies, pharmacological compounds containing these antibodies, their nucleic acids encoded, and expression vectors
ATE537707T1 (de) Lactobacillus paracasei und gewichtskontrolle
GB2460781B (en) Probiotic bifidobacterium strains
GB2465051B (en) Probiotic bifidobacterium strains
DK2657333T3 (da) Porcint circovirus type 2, immunsammensætning indeholdende samme, assaykit og anvendelse deraf
DE602006010723D1 (de) Neues bakterium der gattung bifidobacterium und dessen nutzung
PT2626076T (pt) Utilizações terapêuticas de lactobacillus salivarus ls01 22775
DK1824500T3 (da) Probiotisk lactobacillus-stamme til forbedret vaginal sundhed
CL2012003026A1 (es) Composicion farmaceutica que comprende pioglitazona y linagliptina; procedimiento de preparacion; uso en el tratamiento de la diabetes tipo 2 o la obesidad.
BRPI1014304A2 (pt) bifidobacterium longum ncc2705 (cncm i-2618) e distúrbios imunes
DK1988163T3 (da) Hla-a*3303-begrænset wt1 peptid og farmaceutisk sammensætning omfattende det samme
BRPI0817905A2 (pt) Utilização de uma cepa de bifidobacterium, para o preparo de uma composição destinada à prevenção e/ou ao tratamento de manifestações do tipo alérgicas
MX389112B (es) Uso de probioticos en el tratamiento y/o la prevencion de la enfermedad de la psoriasis.
PL2176299T3 (pl) Polisacharyd wyizolowany z Bifidobacterium infantis 35624 (NCIMB 41003)
BR112015014693A2 (pt) uso de bifidobacterium animalis para o tratamento ou a prevenção de ganho de peso corpóreo e resistência à insulina
DK2802333T3 (da) Lactobacillus rhamnosus og Bifidobacterium animalis subsp. lactis til anvendelse til forebyggelse eller behandling af øvre luftvejsinfektioner
BRPI0807649A2 (pt) Utilização de lactobacillus casei para reforçar a proteção induzida pela vacina antigripal
BRPI1014081A2 (pt) uso de uma bactéria da espécie bifidobacterium animalis subsp lactis cepa 420 (b420) ou uma mistura da mesma
ATE421572T1 (de) Neue stämme von lactobacillus helveticus
ATE536102T1 (de) Probiotischer stamm von lactobacillus delbrueckii subsp bulgaricus
IL210068A0 (en) Compositions and methods of use of orf 554 from beta hemolytic streptococcal strains
ATE423840T1 (de) Neue stämme von lactobacillus helveticus
AP2409A (en) Novel enterococcus and streptococcus strains and bacteriocins.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25D Requested change of name of applicant approved

Owner name: DUPONT NUTRITION BIOSCIENCES APS (DK)

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B25F Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement

Owner name: DUPONT NUTRITION BIOSCIENCES APS (DK)

Free format text: A FIM DE ATENDER A ALTERACAO DE NOME REQUERIDA ATRAVES DA PETICAO NO 870240089625, DE 21/10/2024, E NECESSARIO APRESENTAR UMA GUIA DE RECOLHIMENTO, CODIGO 248, RELATIVA A ALTERACAO DE ENDERECO DA CEDENTE. ALEM DISSO, E PRECISO APRESENTAR A GUIA DE CUMPRIMENTO DE EXIGENCIA.

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/06/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

B25E Requested change of name of applicant rejected

Owner name: DUPONT NUTRITION BIOSCIENCES APS (DK)

Free format text: INDEFERIDO O PEDIDO DE ALTERACAO DE NOME CONTIDO NA PETICAO 870240089625 DE 21/10/2024, POR AUSENCIA DE CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI NO 2831, DE 08/04/2025.

B25D Requested change of name of applicant approved

Owner name: INTERNATIONAL NANDH DENMARK APS (DK)

B25G Requested change of headquarter approved

Owner name: INTERNATIONAL NANDH DENMARK APS (DK)